Methods for preventing restenosis using tocotrienols
CA 2310232 A1 · Owner: Lipogenics, Inc. · Inventors: Lane, Ronald H.; Schneider, Frederick H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to the prevention of restenosis using tocotrienols. Specifically, this invention relates to the use of individual tocotrienols (such as P25 tocotrienol), mixtures of tocotrienols and mixtures of one or more tocotrienols with other substances (such as the TRF25 mixture). The methods of this invention include a method for administering a pharmaceutically acceptable composition comprising a tocotrienol to a patient in need of restenosis prophylaxis and a method for preventing restenosis in a patient undergoing an arterial angioplastic procedure comprising the steps of: (a) coating the exterior surface of an angioplastic balloon with a composition comprising a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 17, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 17, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.